This study exploited the possibility to detect Citrobacter freundii-derived CMY-2-like cephalosporinases in Enterobacteriaceae clinical isolates using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Periplasmic proteins were prepared using a modified sucrose method and analyzed by MALDI-TOF MS. A ca. 39,850-m/z peak, confirmed to represent a C. freundii-like β-lactamase by in-gel tryptic digestion followed by MALDI-TOF/TOF MS, was observed only in CMY-producing isolates. We have also shown the potential of the assay to detect ACC- and DHA-like AmpC-type β-lactamases.

Department of Microbiology Faculty of Medicine and University Hospital in Plzen Charles University Prague Plzen Czech Republic

Zobrazit více v PubMed

Seng P, Rolain JM, Fournier PE, La Scola B, Drancourt M, Raoult D. 2010. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol. 5:1733–1754. 10.2217/fmb.10.127 PubMed DOI

Wieser A, Schneider L, Jung J, Schubert S. 2012. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review). Appl. Microbiol. Biotechnol. 93:965–974. 10.1007/s00253-011-3783-4 PubMed DOI

Hrabák J, Chudácková E, Walková R. 2013. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis. Clin. Microbiol. Rev. 26:103–114. 10.1128/CMR.00058-12 PubMed DOI PMC

Hrabák J, Walková R, Studentová V, Chudácková E, Bergerová T. 2011. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49:3222–3227. 10.1128/JCM.00984-11 PubMed DOI PMC

Burckhardt I, Zimmermann S. 2011. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J. Clin. Microbiol. 49:3321–3324. 10.1128/JCM.00287-11 PubMed DOI PMC

Kempf M, Bakour S, Flaudrops C, Berrazeg M, Brunnel JM, Drissi M, Msli E, Touati A, Rolain JM. 2012. Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS One 7:e31676. 10.1371/journal.pone.0031676 PubMed DOI PMC

Hrabák J, Studentová V, Walková R, Zemlicková H, Jakubu V, Chudácková E, Gniadkowski M, Pfeifer Y, Perry JD, Wilkinson K, Bergerová T. 2012. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapnemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50:2441–2443. 10.1128/JCM.01002-12 PubMed DOI PMC

Camara JE, Hays FA. 2007. Discrimination between wild-type and ampicillin-resistant Escherichia coli by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Bioanal. Chem. 389:1633–1638. 10.1007/s00216-007-1558-7 PubMed DOI

Schaumann R, Knoop N, Gnzel GH, Losensky K, Rosenkranz C, Stîngu CS, Schellenberger W, Rodloff AC, Eschrich K. 2012. A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med. Sci. Monit. 18:MT1–MT77. 10.12659/MSM.883339 PubMed DOI PMC

Jacoby GA. 2009. AmpC beta-lactamases. Clin. Microbiol. Rev. 22:161–182. 10.1128/CMR.00036-08 PubMed DOI PMC

Empel J, Baraniak A, Literacka E, Mrówka A, Fiett J, Sadowy E, Hryniewicz W, Gniadkowski M; Beta-PL Study Group. 2008. Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob. Agents Chemother. 52:2449–2454. 10.1128/AAC.00043-08 PubMed DOI PMC

Pérez-Pérez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153–2162. 10.1128/JCM.40.6.2153-2162.2002 PubMed DOI PMC

Kotsakis SD, Papagiannitsis CC, Tzelepi EE, Tzouvelekis LS, Miriagou V. 2009. Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase. Antimicrob. Agents Chemother. 53:3520–3523. 10.1128/AAC.00219-09 PubMed DOI PMC

Gazouli M, Tzouvelekis LS, Prinarakis E, Miriagou V, Tzelepi E. 1996. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2). Antimicrob. Agents Chemother. 40:1736–1740 PubMed PMC

Mavroidi A, Tzelepi E, Miriagou V, Gianneli D, Legakis NJ, Tzouvelekis LS. 2002. CTX-M-3 beta-lactamase-producing Escherichia coli from Greece. Microb. Drug Resist. 8:35–37. 10.1089/10766290252913737 PubMed DOI

Izdebksi R, Baraniak A, Fiett J, Adler A, Kazma M, Salomon J, Lawrence C, Rossini A, Salvia A, Hryniewicz W, Brun-Buisson C, Carmeli Y, Gniadkowski M; MOSAR WP2 and WP5 Study Groups. 2013. Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinase of Escherichia coli populations colonizing patients in rehabilitation centers in four countries. Antimicrob. Agents Chemother. 57:309–316. 10.1128/AAC.01656-12 PubMed DOI PMC

Tzouvelekis LS, Tzelepi E, Mentis AF. 1994. Nucleotide sequence of a plasmid-mediated cephalosporinase gen (blaLAT-1) found in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 38:2207–2209. 10.1128/AAC.38.9.2207 PubMed DOI PMC

Zioga A, Whichard JM, Kotsakis SD, Tzouvelekis Tzelepi LS E, Miriagou V. 2009. CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids. Antimicrob. Agents Chemother. 53:1256–1259. 10.1128/AAC.01284-08 PubMed DOI PMC

Baraniak A, Izdebski R, Fiett J, Sadowy E, Adler A, Kazma M, Salomon J, Lawrence C, Rossini A, Salvia A, Vidal Samso J, Fierro J, Paul M, Lerman Y, Malhotra-Kumar S, Lammens C, Goossens H, Hryniewicz W, Brun-Buisson C, Carmeli Y, Gniadkowski M; MOSAR WP2 and WP5 Study Groups. 2013. Comparative population analysis of Klebsiella pneumoniae strains with extended-spectrum β-lactamases colonizing patients in rehabilitation centers in four countries. Antimicrob. Agents Chemother. 57:1992–1997. 10.1128/AAC.02571-12 PubMed DOI PMC

D'Andrea MM, Leteracka E, Zioga A, Giani T, Baraniak A, Fiett Sadowy JE, Tassios PT, Rossolini GM, Gniadkowski M, Miriagou V. 2011. Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinase in Europe. Antimicrob. Agents Chemother. 55:2735–2742. 10.1128/AAC.01736-10 PubMed DOI PMC

Papagiannitsis CC, Miriagou V, Kotsakis SD, Tzelepi E, Vatopoulos AC, Petinaki E, Tzouvelekis LS. 2012. Characterization of a transmissible plasmid encoding VEB-1 and VIM-1 in Proteus mirabilis. Antimicrob. Agents Chemother. 56:4024–4025. 10.1128/AAC.00470-12 PubMed DOI PMC

Naglak TJ, Wang HY. 1990. Recovery of a foreign protein from the periplasm of Escerichia coli by chemical permeabilization. Enzyme Microb. Technol. 12:603–611. 10.1016/0141-0229(90)90134-C PubMed DOI

Kotsakis SD, Caselli E, Tzouvelekis LS, Petinaki E, Prati F, Miriagou V. 2013. Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42. Antimicrob. Agents Chemother. 57:968–976. 10.1128/AAC.01620-12 PubMed DOI PMC

Mares J, Richtrova P, Hricinova A, Tuma Z, Moravec J, Jysak D, Matejovic M. 2010. Proteomic profiling of blood-dialyzer interactome reveals involvement of lectin complement pathway in hemodialysis-induced inflammatory response. Proteomics Clin. Appl. 4:829–838. 10.1002/prca.201000031 PubMed DOI

Papagiannitsis CC, Tzouvelekis LS, Tzelepi E, Miriagou V. 2007. Plasmid encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli. Antimicrob. Agents Chemother. 51:3763–3767. 10.1128/AAC.00389-07 PubMed DOI PMC

Empel J, Hrabak J, Kozinska A, Bergerova T, Ubraskova P, Kern-Zdanowicz I, Gniadkowski M. 2010. DHA-1-producing Klebsiella pneumoniae in a teaching hospital in the Czech Republic. Microb. Drug Resist. 16:291–295. 10.1089/mdr.2010.0030 PubMed DOI

Cai JC, Hu YY, Zhang R, Zhou HW, Chen GX. 2012. Detection of OMPK36 proin loss in Klebsiella spp. by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50:2179–2182. 10.1128/JCM.00503-12 PubMed DOI PMC

Combination of mass spectrometry and DNA sequencing for detection of antibiotic resistance in diagnostic laboratories